• Info
  • Insider Trading

Insider Transactions Reported by 12 Insiders of Translate Bio, Inc.

Location
Lexington, MA

There are no Buy or Sell transactions made by insiders since 13 Mar 2025

Translate Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sanofi 10%+ Owner $2,875,385,178 14 Sep 2021
Brendan Smith Chief Financial Officer 14 Sep 2021
Robert M. Plenge Director 14 Sep 2021
BAUPOST GROUP LLC/MA 10%+ Owner 14 Sep 2021
Everett Rand Sutherland President 14 Sep 2021
George Demetri Director 14 Sep 2021
Paul D. Burgess Chief Operating Officer, CLO, Secretary 14 Sep 2021
Daniella Beckman Director 14 Sep 2021
Owen Hughes Director 14 Sep 2021
JEAN FRANCOIS FORMELA Director 14 Sep 2021
Robert J. Meyer Director 14 Sep 2021
Ronald C. Renaud JR Chief Executive Officer, Director 14 Sep 2021

Recent Insider Transactions by Companies or Individuals for Translate Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Everett Rand Sutherland Stock Option (right to buy) Sale -100% -300,000 0 14 Sep 2021 Direct
Brendan Smith Stcok Option (right to buy) Sale -100% -201,800 0 14 Sep 2021 Direct
Paul D. Burgess Common Stock Sale -100% -71,833 0 14 Sep 2021 Direct
Paul D. Burgess Stock Option (right to buy) Sale -100% -679,605 0 14 Sep 2021 Direct
Robert M. Plenge Stock Option (right to buy) Sale -100% -95,600 0 14 Sep 2021 Direct
Robert J. Meyer Stock Option (right to buy) Sale -100% -95,600 0 14 Sep 2021 Direct
George Demetri Stock Option (right to buy) Sale -100% -76,700 0 14 Sep 2021 Direct
George Demetri Stock Option (right to buy) Sale -100% -76,700 0 14 Sep 2021 Direct
Owen Hughes Common Stock Sale -100% -29,860 0 14 Sep 2021 Direct
Owen Hughes Stock Option (right to buy) Sale -100% -75,935 0 14 Sep 2021 Direct
Owen Hughes Stock Option (righ to buy) Sale -100% -20,000 0 14 Sep 2021 Direct
Daniella Beckman Stock Option (right to buy) Sale -100% -125,795 0 14 Sep 2021 Direct
Ronald C. Renaud JR Common Stock Sale -100% $19,122,778 $38.00 -503,231 0 14 Sep 2021 Direct
Ronald C. Renaud JR Common Stock Sale -100% $15,576,694 $38.00 -409,913 0 14 Sep 2021 By Ronald Renaud 2014 Irrevocable Family Trust
Ronald C. Renaud JR Common Stock Sale -100% $1,554,542 $38.00 -40,909 0 14 Sep 2021 By Ronald C. Renaud, Jr. Trust - 2007
Ronald C. Renaud JR Stock Option (right to buy) Sale -100% -2,186,005 0 14 Sep 2021 Direct
Ronald C. Renaud JR Stcok Option (right to buy) Sale -100% -325,000 0 14 Sep 2021 Direct
Sanofi Common Stock, par value $0.001 per share Purchase 1953.7% $2,735,376,686 $38.00 71,983,597 75,668,031 14 Sep 2021 Direct
Baupost Group Llc/Ma Common Stock Other -100% -18,044,239 0 14 Sep 2021 See footnote 1 and 2
JEAN FRANCOIS FORMELA Common Stock Sale -100% -2,055,063 0 14 Sep 2021 See Footnote
JEAN FRANCOIS FORMELA Stock Option (right to buy) Sale -100% -95,600 0 14 Sep 2021 Direct
Robert J. Meyer Stock Option (right to buy) Award 20,000 20,000 16 Jun 2021 Direct
Robert M. Plenge Stock Option (right to buy) Award 20,000 20,000 16 Jun 2021 Direct
George Demetri Stock Option (right to buy) Award 20,000 20,000 16 Jun 2021 Direct
Owen Hughes Stock Option (right to buy) Award 20,000 20,000 16 Jun 2021 Direct
Daniella Beckman Stock Option (right to buy) Award 20,000 20,000 16 Jun 2021 Direct
JEAN FRANCOIS FORMELA Common Stock (right to buy) Award 20,000 20,000 16 Jun 2021 Direct
Ronald C. Renaud JR Common Stock Options Exercise 1.83% 9,026 503,231 07 Apr 2021 Direct
Ronald C. Renaud JR Stock Option (right to buy) Options Exercise -0.84% -9,026 1,071,009 07 Apr 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.